AJR AJR-based Continuing Ed for Technologists
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Figures Only
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Karimova, E. J.
Right arrow Articles by Kaste, S. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Karimova, E. J.
Right arrow Articles by Kaste, S. C.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Hotlight (NEW!)
Right arrow
What's Hotlight?
DOI:10.2214/AJR.04.1597
AJR 2006; 186:477-482
© American Roentgen Ray Society


Original Research

MRI of Knee Osteonecrosis in Children with Leukemia and Lymphoma: Part 2, Clinical and Imaging Patterns

Evguenia J. Karimova1, Shesh N. Rai1, David Ingle2, Amy C. Ralph2, Xin Deng1, Michael D. Neel1, Scott C. Howard1, Ching-Hon Pui1 and Sue C. Kaste1

1 Department of Radiological Sciences, Division of Diagnostic Imaging, St. Jude Children's Research Hospital, 332 N Lauderdale St., Memphis, TN 38105.
2 University of Tennessee College of Medicine, Memphis, TN.

Received October 12, 2004; accepted after revision March 22, 2005.

 
Supported in part by grants P30 CA-21765 and P01 CA-20180 from the National Institutes of Health, a Center of Excellence grant from the State of Tennessee, and by the American Lebanese Syrian Associated Charities (ALSAC).

Address correspondence to S. C. Kaste.


Abstract
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
 
OBJECTIVE. This aim of this study was to explore the relationship between MRI findings and clinical symptoms of knee osteonecrosis in children and to determine the significance of this relationship. Such information is important for early diagnosis of this frequent complication and for choosing an appropriate treatment strategy.

MATERIALS AND METHODS. Osteonecrotic lesion size and location were determined in a retrospective analysis of MR images of the knee obtained in our institution during the past 10 years. Association between MRI findings and clinical symptoms expressed by the knee scores was tested for a subgroup of our patient population who had clinical evaluation of the knees in the orthopedic clinic within 6 weeks of their MRI studies.

RESULTS. In 80% of patients, osteonecrosis was bilateral. Lesions were distributed as follows: femur and tibia, 66% of the knees; femur alone, 26%; and tibia alone, 8%. Clinical symptoms of knee osteonecrosis were associated with lesions involving the articular surface of the distal femur, large lesions, and involvement of any part of the tibia. MR images showed milder osteonecrosis in patients who were less than 10 years old at the time of primary diagnosis.

CONCLUSION. Osteonecrosis affecting the knees of children treated for leukemia and lymphoma is mostly asymptomatic. Children who are 10 years old or older have signs of more advanced osteonecrosis. Clinical symptoms often lag MRI presentation and may develop late in the course of the disease. Routine MRI evaluation is recommended for timely diagnosis of treatment-induced osteonecrosis.

Keywords: knee • leukemia • lymphoma • MRI • musculoskeletal imaging • oncology • osteonecrosis • pediatric imaging


Introduction
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
 
Corticosteroid-induced osteonecrosis of the knee in children treated for leukemia has generally been described together with osteonecrosis of other joints [1-7]. Osteonecrosis, in any location, has been reported in as many as 38% (95% confidence interval [CI], 19-59%) of patients with the most common type of childhood leukemia, acute lymphoblastic leukemia (ALL) [2]. The morbidity of steroid-induced osteonecrosis of the knee is severe in adult patients, who may need arthroplasty [8]. Progression and outcomes of osteonecrosis in children are less well documented, although surgical treatment for osteonecrosis of the knees has been reported in pediatric leukemia survivors [3, 4].

The association between MRI findings and symptoms or signs of osteonecrosis of the knee, and the clinical significance of the association, have not yet been established for children. Such information could be valuable in assessing the potential seriousness of this relatively frequent complication. In this article we report the demographic, MRI, and clinical findings associated with osteonecrosis of the knee, and the relation between the MRI and clinical findings, in children treated for hematologic malignancy at a pediatric cancer center. To explore this relationship, we tested the association between clinical symptoms and MRI findings of osteonecrosis in a subgroup of patients for whom orthopedic clinical data were available. We also describe MRI patterns of involvement and their influence on clinical manifestations of knee osteonecrosis.


Materials and Methods
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
 
Data Collection
After obtaining approval from our institutional review board, we conducted a retrospective review of successive MR images of the knee of pediatric patients with hematologic malignancies that had been obtained at our institution between April 1994 and July 2003. Patients underwent MRI studies for the following reasons: Most patients whose MRI studies were recorded participated in research protocols that monitored the development of bony abnormalities during (80/302) or after (125/302) oncologic treatment and routinely underwent MRI regardless of symptoms. Also, some patients outside these groups (97/302) were referred for MRI for clinical indications (e.g., persistent knee pain). None of patients with symptomatic osteonecrosis who underwent MRI was omitted. These selection criteria may have resulted in omission of a small number of patients with asymptomatic knee osteonecrosis; however, this omission is not sufficiently significant to affect the results of our study. Osteonecrosis was identified in 303 knees of 168 children who had a primary diagnosis of hematologic malignancy (median age, 10 years; range, 1.0-18.8 years). No patients were excluded. MRI evaluation of the knees consisted of coronal unenhanced T1-weighted (TR/TE, 400/14) images, coronal STIR (3,550/28) images, and sagittal FLASH (fast low-angle shot) 2D (588/10.5) images. All MRI was performed on one of three Siemens 1.5-T scanners (Helicon, Vision, or Symphony) and was reviewed on a PACS and interpreted by one of two reviewers who had been instructed in image interpretation by a senior pediatric oncologic imager. The interobserver reliability of the two reviewers was measured by comparing their interpretation of 36 randomly selected MR studies of individual patients and was then described using the kappa statistic [9, 10].

We divided the knee into eight zones and recorded the presence or absence of an osteonecrotic lesion in each zone: distal femoral diaphysis, distal femoral metaphysis, medial and lateral distal femoral epiphyses, medial and lateral proximal tibial epiphyses, proximal tibial metaphysis, and proximal tibial diaphysis (Figs. 1A and 1B). An osteonecrotic lesion was defined as a geographic area of decreased signal on T1-weighted images and increased signal on STIR images. We recorded additional characteristics of lesions located in epiphyseal zones, including whether the lesion reached the articular surface and what percentage (< 25%, 25-50%, or > 50%) of the articular surface was involved.


Figure 1
View larger version (149K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 1A —10-year-old girl with acute lymphoblastic leukemia. Coronal T1-weighted unenhanced MR image of knees (A) and diagram (B) show osteonecrosis as geographic areas of decreased signal. Right knee: A = Distal femoral diaphysis, not visible on this image. B = Distal femoral metaphysis, osteonecrotic lesion present. C = Medial distal femoral epiphysis, osteonecrotic lesion not involving articular surface. D = Lateral distal femoral epiphysis, osteonecrotic lesion involving 25-50% of articular surface. E = Medial proximal tibial epiphysis, osteonecrotic lesion involving < 25% of articular surface. F = Lateral proximal tibial epiphysis, osteonecrotic lesion involving < 25% of articular surface. G = Proximal tibial metaphysis, osteonecrotic lesion present. H = Proximal tibial diaphysis, osteonecrotic lesion present. Left knee: A' = Distal femoral diaphysis, not visible on this image. B' = Distal femoral metaphysis, osteonecrotic lesion present. C' = Medial distal femoral epiphysis, osteonecrotic lesion not involving articular surface. D' = Lateral distal femoral epiphysis, osteonecrotic lesion involving 25-50% of articular surface. E' = Medial proximal tibial epiphysis, osteonecrotic lesion not involving articular surface. F' = Lateral proximal tibial epiphysis, osteonecrotic lesion not involving articular surface. G' = Proximal tibial metaphysis, osteonecrotic lesion present. H' = Proximal tibial diaphysis, osteonecrotic lesion present.

 

Figure 2
View larger version (26K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 1B —10-year-old girl with acute lymphoblastic leukemia. Coronal T1-weighted unenhanced MR image of knees (A) and diagram (B) show osteonecrosis as geographic areas of decreased signal. Right knee: A = Distal femoral diaphysis, not visible on this image. B = Distal femoral metaphysis, osteonecrotic lesion present. C = Medial distal femoral epiphysis, osteonecrotic lesion not involving articular surface. D = Lateral distal femoral epiphysis, osteonecrotic lesion involving 25-50% of articular surface. E = Medial proximal tibial epiphysis, osteonecrotic lesion involving < 25% of articular surface. F = Lateral proximal tibial epiphysis, osteonecrotic lesion involving < 25% of articular surface. G = Proximal tibial metaphysis, osteonecrotic lesion present. H = Proximal tibial diaphysis, osteonecrotic lesion present. Left knee: A' = Distal femoral diaphysis, not visible on this image. B' = Distal femoral metaphysis, osteonecrotic lesion present. C' = Medial distal femoral epiphysis, osteonecrotic lesion not involving articular surface. D' = Lateral distal femoral epiphysis, osteonecrotic lesion involving 25-50% of articular surface. E' = Medial proximal tibial epiphysis, osteonecrotic lesion not involving articular surface. F' = Lateral proximal tibial epiphysis, osteonecrotic lesion not involving articular surface. G' = Proximal tibial metaphysis, osteonecrotic lesion present. H' = Proximal tibial diaphysis, osteonecrotic lesion present.

 

To study the relationship between MRI findings and clinical symptoms, we identified all patients who had knee scores [11] obtained in the orthopedic clinic within 6 weeks of their MRI study. We chose this abbreviated time interval because of the rapid progression of osteonecrosis we have observed in some patients; a longer time interval might have resulted in inaccurate perception of such relationship. Patients were referred for the orthopedic assessment by clinicians if osteonecrosis was discovered on MRI. The knee score was developed by the Knee Society [11] as a measure of clinical symptoms associated with knee arthritis in adults (pain, limitation in the range of motion, and joint instability). The knee score rates only the joint itself and does not involve functional assessment, thus eliminating potentially confounding factors of patient infirmity. Scores range from 0 to 100, with the highest score indicating the absence of pain, perfect alignment and range of motion, and no joint instability [11]. The knee score is combined from a quantitative evaluation of pain, range of motion, and stability. Pain is the major contributor to the score; 50 points are assigned to patients who report no pain, and 45 points are assigned for mild or occasional pain. Range of motion and stability contribute up to 25 points each to the score. Flexion contracture, extension lag, and misalignment are dealt with as deductions. In our group of patients, the score of 95 in all 22 knees was due to mild or occasional pain. The same orthopedic surgeon and nurse obtained the knee scores from all patients. To address the potentially confounding effect of hip osteonecrosis on clinical manifestations of knee osteonecrosis, hip involvement of a subgroup of patients with knee osteonecrosis and knee scores was identified from hip MR images.

Estimation of Disease Severity
We used the estimated percentage of the articular surface involved by an osteonecrotic lesion as an indicator of disease severity. Several studies of the natural course of osteonecrosis in adult and pediatric populations concluded that a worse prognosis was associated with the presence of large epiphyseal lesions and involvement of the articular surface [6, 8, 12]. For this analysis, we defined "large" epiphyseal lesions as those involving more than 25% of the articular surface of the medial or lateral portion of the femoral or tibial epiphysis. We calculated the prevalence of such lesions according to age group, sex, and race.

Statistical Analysis
For statistical analysis of the association between Knee Society score and the number of different types of osteonecrotic lesions, we used Fisher's exact test (for 2 x 2 tables) and Wilcoxon's rank sum test (for 2 x p ordered tables). The strength of agreement between the two observers was determined using kappa statistics, as suggested by Landis and Koch [10].


Results
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
 
Demographics
Of the 168 patients with osteonecrosis of the knee, 142 were white, 21 black, and five of other races; 90 were boys and 78 were girls. The primary diagnoses were ALL (n =153), acute myeloblastic leukemia (n = 7), chronic myeloid leukemia (n= 1), and lymphoma (n= 7). The median age at the time of primary diagnosis was 10 years (range, 1.0-18.8 years). The subcohort of patients with knee scores obtained within 6 weeks of MRI consisted of 47 patients and, on the basis of the key demographic characteristics (sex, race, and age at diagnosis), was representative of the main cohort. In the group of 47 patients, 26 were girls and 21 were boys, 39 were white, the median age was 10.9 years (range, 2.0-17.1 years), 46 patients had leukemia, and one had lymphoma.

MRI Evaluation
Eighty percent of the affected patients (135/168) had bilateral knee osteonecrosis. In 66% (200/303) of the affected knees, osteonecrosis was present in both the femur and the tibia. In 26% (79/303), lesions were present only in the distal femur; in 8% (24/303), only in the proximal tibia.

The frequency of large epiphyseal lesions (affecting > 25% of articular surface) increased with the patient's age. Approximately 10% (8/84) of patients less than 10 years old at the diagnosis of cancer had large epiphyseal lesions. In contrast, approximately half (41/84) of those 10 years old or older had large epiphyseal lesions (p = 0.0001). Race and sex were not found to be associated with the presence of large epiphyseal lesions (p = 0.6131 and p = 0.4466, respectively).

Children less than 10 years old had bilateral knee involvement slightly less often than did the older group: 76% (64/84) versus 90% (76/84) (p = 0.013). Similarly, they had fewer osteonecrotic lesions overall (463 vs 743; p < 0.0001), fewer epiphyseal lesions (288 vs 381; p = 0.0004), and fewer lesions extending to the articular surface (28 vs 175; p < 0.0001). The two age groups were equal in size (84 patients) and therefore could be directly compared.

Relationship Between Clinical Symptoms and MRI Findings of Knee Osteonecrosis
Clinical evaluation—Knee scores were obtained within 6 weeks of imaging for 93 knees (of 47 patients) that showed MRI evidence of osteonecrosis. More than half of the knees (51, 55%) were asymptomatic (knee score = 100); 22 (24%) had a score of 95; and only 20 (22%) had a score of less than 95. The median score was 100 (range, 50-100) because of the large number of asymptomatic knees. Because most knees (51/93) had a perfect knee score of 100, we used the presence (score < 100) or absence (score = 100) of knee-related symptoms to test the relationship between the clinical and MRI findings. Hip osteonecrosis was identified in 20 cases: 16 related to symptomatic knees and four related to asymptomatic knees. In the subgroup of patients with no hip osteonecrosis, 64% of knees (47/73) were asymptomatic, and 36% (26/73) were symptomatic.

Relationship between knee score and frequency of osteonecrotic damage to metaphysis and diaphysis—Osteonecrotic lesions in the distal femoral diaphysis and metaphysis were not found to be associated with symptoms; lesions in the proximal tibial metaphysis or diaphysis were (Table 1).


View this table:
[in this window]
[in a new window]

 
TABLE 1: Comparison of Frequency of Osteonecrotic Damage to Metaphysis and Diaphysis Between Symptomatic and Asymptomatic Knees with Osteonecrosis

 

Relationship of knee score to type and frequency of osteonecrotic damage to epiphysis—The distribution of different types of epiphyseal lesions in symptomatic and asymptomatic groups is shown in Table 2. Epiphyseal lesions of any type were associated with symptoms in the femur and the tibia (p < 0.001). Among epiphyses with osteonecrotic lesions, involvement of the articular surface was associated with the presence of symptoms (femur, p < 0.09; tibia, p= 0.034). Among femoral epiphyses with osteonecrotic lesions involving the articular surface, the extent of articular surface involvement was strongly associated with the presence of symptoms (p < 0.001). However, in tibial epiphyses, we found no association between the size of lesions involving the tibial articular surface and symptoms (p= 0.663).


View this table:
[in this window]
[in a new window]

 
TABLE 2: Number and Types of Osteonecrotic Lesions in Epiphyses of Symptomatic and Asymptomatic Knees with Osteonecrosis

 

Relationship between extent of osteonecrotic damage to epiphysis and knee score— Epiphyseal involvement was highly prevalent in knees with osteonecrosis (Table 3). Osteonecrosis involving at least one epiphyseal zone (in femur or tibia) was about equally prevalent among symptomatic and asymptomatic knees (40/42 vs 44/51, p = 0.1577; Table 3). Symptomatic knees had articular surface involvement significantly more often than did asymptomatic knees (31/42 vs 22/51, p= 0.0092; Table 3). In addition, the size of surface-involving lesions differed between symptomatic and asymptomatic knees (p= 0.0028), with the former tending to have larger lesions. In the symptomatic group, 67% of the knees (28/42) had lesions with substantial (> 25%) articular surface involvement. In the asymptomatic group, 25.5% (13/51) had such lesions (Table 3). The difference is even more striking for lesions involving more than 50% of the articular surface: 12% (6/51) of asymptomatic knees had such lesions compared with 48% (20/42) of symptomatic knees. Three symptomatic and nine asymptomatic knees had lesions involving less than 25% of the surface. It appears that lesions with less than 25% of articular surface involvement are more likely to be asymptomatic.


View this table:
[in this window]
[in a new window]

 
TABLE 3: Distribution of Symptomatic and Asymptomatic Knees by Most Extensive Epiphyseal Lesion Anywhere in Knee

 

Reliability
Interobserver reliability in using the osteonecrosis classification system was substantial: {kappa} = 0.66 (95% CI, 0.58-0.75) in locations where only the presence or absence of a lesion was recorded and weighted {kappa} = 0.65 (95% CI, 0.59-0.72) in locations where the extent of involvement was recorded. Additional information regarding the interobserver reliability assessment is described in part 1 of this series [13].


Discussion
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
 
Significance of Treatment-Induced Osteonecrosis in Pediatric Leukemia Patients
Osteonecrosis of the knee is a recognized complication of current therapy for pediatric hematologic malignancies. However, little information is available about the clinical significance of MRI evidence of osteonecrosis of the knee in children. Such information is important for early detection of this complication and for choosing an appropriate treatment strategy. Previous reports of the incidence of symptomatic osteonecrosis in any site have ranged from 1.1% to 9.3%, and an age of 10 or more years at diagnosis is reportedly a risk factor for the development of osteonecrosis [1, 3, 7, 14]. A prospective study of 25 pediatric patients with ALL [15] found osteonecrosis of the knees in four (16%). Two other prospective studies of pediatric ALL [2, 16] reported a much higher rate (38%) of osteonecrosis, most of which cases were asymptomatic. In one of these studies, age at diagnosis was not found to be a risk factor [2]. These findings agree with the results of our analysis, which examined the relationship between clinical and MRI manifestations of knee osteonecrosis. In our study, most patients had asymptomatic or minimally symptomatic osteonecrosis, and the presence of clinical symptoms was associated with advanced osteonecrosis extensively involving the articular surface. The frequency and extent of osteonecrosis involvement differed significantly with age: in patients 10 years and older, the articular surface was involved more frequently, and articular lesions were larger. Most of the articular damage occurred in older children. This finding may explain why previous studies that reported results only for patients with symptomatic osteonecrosis included few patients younger than 10 years. It also explains why studies of symptomatic osteonecrosis found the age of 10 or more years at diagnosis to be a risk factor for osteonecrosis [1, 3, 7, 14] and why age was not found to be a risk factor in one of the prospective MRI screenings of all children at risk [2].

MRI evidence of milder osteonecrosis in children younger than 10 years may be associated with fewer patients with clinical symptoms. This finding could lead to the underdiagnosis of osteonecrosis in this age group. It is also more difficult to elicit information about clinical symptoms, especially very mild ones, from younger patients. Studies of the natural course of steroid-induced osteonecrosis showed that large lesions close to the articular surface were associated with a progressive course of osteonecrosis and with a higher rate of treatment failure [6, 8]. The higher prevalence of large epiphyseal lesions that we found in children 10 years or older may indicate that osteonecrosis of the knee leads to a worse outcome in this age group.

Association Between Clinical Symptoms and MRI Findings of Knee Osteonecrosis
Of the 93 knees in our study with available knee scores, more than half (51) were asymptomatic (knee score = 100); 22 had a score of 95, and only 20 knees had a score of less than 95. Only three of 93 cases revealed isolated tibial involvement, which did not allow us to separate the influence of tibial versus femoral lesions on clinical symptoms. Clinical symptoms were associated with lesions in any part of the tibia. In the case of femoral lesions, clinical symptoms were associated with large lesions involving the articular surface. Epiphyseal lesions that did not extend to the articular surface were not found to be associated with symptoms. Although the presence of large surface lesions was associated with symptoms, a substantial number of the knees with large surface lesions (13/41, 32%) were asymptomatic. Furthermore, even when the lesions involved more than 50% of the articular surface, six (23%) of 26 knees were asymptomatic (Table 3). This finding may mean that therapy-induced osteonecrosis of the knee becomes symptomatic late in its progression when the articular surface is substantially involved. Even then, clinical symptoms may be absent in many cases. Therefore, clinical symptoms are not a reliable diagnostic sign of osteonecrosis of the knees in children.

Asymptomatic osteonecrosis is common. In two prospective screening studies of ALL patients, osteonecrosis was diagnosed in more than 30% of patients, and one half to two thirds of those with a diagnosis of osteonecrosis were asymptomatic [2, 16]. Our data closely agree with those previously reported. In our group of 93 knees with available function scores, 51 (55%) were completely asymptomatic and 22 (24%) had scores of 95 due to mild or occasional pain. Considering the somewhat subjective nature of pain evaluation, which is especially challenging in the pediatric population, some patients with a knee score of 95 might have been considered asymptomatic at a repeated evaluation. Elimination of hip osteonecrosis as a confounding factor for clinical manifestations of knee osteonecrosis increases the proportion of asymptomatic knees: 64% (47/73) versus 55% (51/93). When it is asymptomatic, osteonecrosis may not be diagnosed unless patients are prospectively monitored with imaging. Undiagnosed, asymptomatic osteonecrosis does not present a problem when it resolves without the need for treatment [6, 16]. However, osteonecrosis that is initially asymptomatic may progress to become symptomatic later [8, 17-19]. A significant percentage of patients with ALL and symptomatic osteonecrosis require surgical treatment [3]. The most significant morbidity ensues when osteonecrosis develops in a weight-bearing joint, such as the hip or knee, and when lesions are located in the epiphysis. Longitudinal studies of osteonecrosis in adults show improved results when treatment is initiated at an early stage [20-22]. However, the benefit of early intervention for knee osteonecrosis, such as cessation of glucocorticoid treatment or core decompression, remains to be shown in a pediatric population.

The limitations of this study include its retrospective nature. Clinical orthopedic data were available for only a modest number of patients. This limitation prompted us to use qualitative (asymptomatic vs symptomatic) instead of quantitative measurements of clinical symptoms. Also, we assumed that an MRI pattern (a large lesion extending to the articular surface) was an indicator of a progressive course of osteonecrosis. A longitudinal study of knee osteonecrosis in this population is needed to fully understand the clinical implications of MRI findings indicative of osteonecrosis. A prospective study would also address a potential limitation of the current study—namely, it would provide information about the protractability and timing of symptom development during the course of treatment.

In conclusion, asymptomatic osteonecrosis of the knee is more common than the symptomatic type among children treated for ALL. Although clinical symptoms usually signify substantial damage, they cannot be relied on as an indicator of the presence or absence of osteonecrosis of the knees. Clinical symptoms often lag MRI presentation and may occur late in the course of the disease. Because it is not known how often patients with asymptomatic knee osteonecrosis subsequently experience symptomatic or progressive joint destruction, further longitudinal investigation is needed. Children 10 years or older at the time of the primary diagnosis of hematologic malignancy may be at greater risk than those who are younger for further progression of osteonecrosis.


Acknowledgments
 
We thank Margaret Carbaugh for her editorial assistance and manuscript preparation.


References
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
 

  1. Ribeiro RC, Fletcher BD, Kennedy W, et al. Magnetic resonance imaging detection of avascular necrosis of the bone in children receiving intensive prednisone therapy for acute lymphoblastic leukemia or non-Hodgkin lymphoma. Leukemia 2001;15 : 891-897[CrossRef][Medline]
  2. Ojala AE, Lanning FP, Paakko E, Lanning BM. Osteonecrosis in children treated for acute lymphoblastic leukemia: a magnetic resonance imaging study after treatment. Med Pediatr Oncol1997; 29:260 -265[CrossRef][Medline]
  3. Mattano LA Jr, Sather HN, Trigg ME, Nachman JB. Osteonecrosis as a complication of treating acute lymphoblastic leukemia in children: a report from the Children's Cancer Group. J Clin Oncol2000; 18:3262 -3272[Abstract/Free Full Text]
  4. Werner A, Jager M, Schmitz H, Krauspe R. Joint preserving surgery for osteonecrosis and osteochondral defects after chemotherapy in childhood. Klin Padiatr 2003;215 : 332-337[CrossRef][Medline]
  5. Murphy RG, Greenberg ML. Osteonecrosis in pediatric patients with acute lymphoblastic leukemia. Cancer1990; 65:1717 -1721[CrossRef][Medline]
  6. Korholz D, Bruder M, Engelbrecht V, Ruther W, Gobel U. Aseptic osteonecrosis in children with acute lymphoblastic leukemia. Pediatr Hematol Oncol 1998;15 : 307-315[Medline]
  7. Strauss AJ, Su JT, Dalton VM, Gelber RD, Sallan SE, Silverman LB. Bony morbidity in children treated for acute lymphoblastic leukemia. J Clin Oncol 2001;19 : 3066-3072[Abstract/Free Full Text]
  8. Mont MA, Baumgarten KM, Rifai A, Bluemke DA, Jones LC, Hungerford DS. Atraumatic osteonecrosis of the knee. J Bone Joint Surg Am 2000; 82:1279 -1290[Abstract/Free Full Text]
  9. Kundel HL, Polansky M. Measurement of observer agreement. Radiology 2003;228 : 303-308[Abstract/Free Full Text]
  10. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977;33 : 159-174[CrossRef][Medline]
  11. Insall JN, Dorr LD, Scott RD, Scott WN. Rationale of the Knee Society clinical rating system. Clin Orthop1989; 248:13 -14
  12. Engelbrecht V, Scherer A, Bruder M, Korholz D, Modder U. MRI of aseptic osteonecrosis in children and adolescents with acute lymphoblastic leukemia [in German]. Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr 2000; 172:336 -341[Medline]
  13. Karimova EJ, Rai SM, Deng X, et al. MRI of osteonecrosis in children with leukemia and lymphoma. Part 1: Observer agreement. AJR 2006; 186:470 -476[Abstract/Free Full Text]
  14. Arico M, Boccalatte MF, Silvestri D, et al. Osteonecrosis: an emerging complication of intensive chemotherapy for childhood acute lymphoblastic leukemia. Haematologica2003; 88:747 -753[Medline]
  15. Pieters R, van Brenk AI, Veerman AJ, van Amerongen AH, van Zanten TE, Golding RP. Bone marrow magnetic resonance studies in childhood leukemia: evaluation of osteonecrosis. Cancer 1987;60 : 2994-3000[CrossRef][Medline]
  16. Ojala AE, Paakko E, Lanning FP, Lanning M. Osteonecrosis during the treatment of childhood acute lymphoblastic leukemia: a prospective MRI study. Med Pediatr Oncol 1999;32 : 11-17[CrossRef][Medline]
  17. Jergesen HE, Khan AS. The natural history of untreated asymptomatic hips in patients who have non-traumatic osteonecrosis. J Bone Joint Surg Am 1997; 79:359 -363[Abstract/Free Full Text]
  18. Kopecky KK, Braunstein EM, Brandt KD, et al. Apparent avascular necrosis of the hip: appearance and spontaneous resolution of MR findings in renal allograft recipients. Radiology1991; 179:523 -527[Abstract/Free Full Text]
  19. Ito H, Matsuno T, Kaneda K. Prognosis of early stage avascular necrosis of the femoral head. Clin Orthop1999; 358:149 -157
  20. Bozic KJ, Zurakowski D, Thornhill TS. Survivorship analysis of hips treated with core decompression for nontraumatic osteonecrosis of the femoral head. J Bone Joint Surg Am 1999;81 : 200-209[Abstract/Free Full Text]
  21. Beltran J, Knight CT, Zuelzer WA, et al. Core decompression for avascular necrosis of the femoral head: correlation between long-term results and preoperative MR staging. Radiology1990; 175:533 -536[Abstract/Free Full Text]
  22. Lavernia CJ, Sierra RJ, Grieco FR. Osteonecrosis of the femoral head. J Am Acad Orthop Surg 1999;7 : 250-261[Abstract]

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Am. J. Roentgenol.Home page
E. J. Karimova, S. N. Rai, X. Deng, D. J. Ingle, A. C. Ralph, M. D. Neel, and S. C. Kaste
MRI of Knee Osteonecrosis in Children with Leukemia and Lymphoma: Part 1, Observer Agreement
Am. J. Roentgenol., February 1, 2006; 186(2): 470 - 476.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Figures Only
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Karimova, E. J.
Right arrow Articles by Kaste, S. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Karimova, E. J.
Right arrow Articles by Kaste, S. C.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Hotlight (NEW!)
Right arrow
What's Hotlight?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS